Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Andres J. Klein-Szanto"'
Autor:
Barbara C. Vanderhyden, Mary K. Senterman, Michael W. Sill, Andres J. Klein-Szanto, Tanya J. Shaw, Roger B. Lee, Russell J. Schilder, Zoe Miner
Publikováno v:
Journal of Clinical Oncology. 26:3418-3425
Purpose This phase II trial assessed the activity and tolerability of an oral dose of imatinib mesylate 400 mg twice daily in patients with recurrent or persistent epithelial ovarian or primary peritoneal carcinoma. The association between the expres
Autor:
C. Renner, Jonathan D. Cheng, Andres J. Klein-Szanto, Leonard R. Henry, Eric A. Ross, John S. Lee, P. Watts, W.-T. Chen
Publikováno v:
Journal of Clinical Oncology. 23:9668-9668
9668 Background: Human Fibroblast Activation Protein (FAP)/seprase is a 97-kd surface glycoprotein with dipeptidyl peptidase and gelatinolytic activity expressed on tumor associated fibroblasts in the majority of epithelial cancers including colon ad